Here at Tjoapack, we provide flexible pharmaceutical serialization solutions for our customers. Our comprehensive knowledge of global market requirements means we can offer our customers guidance and support to achieve full compliance with both the European Falsified Medicines Directive (Directive 2011/62/EU) (EU FMD) and the US Drug Supply Chain Security Act (public law 113-54-Nov.27, 2013) (DSCSA), as well as other market regulations.
Expert insight forming robust serialization solutions
We understand the complexities associated with serialization and we know how important it is to make the implementation process as simple as possible. We work with our customers to create a robust solution that suits their requirements. This means they can continue to supply vital medicines to market.Find out more
Although aggregation is not a legal requirement in every market, it offers the industry huge potential in terms of streamlining the supply chain. With our own developed process, we can aggregate cartons to shipper to pallet.
Our aggregation capabilities, combined with our serialization hardware and software along with a cloud solution, provided by our partner Meditraq, mean that we offer a complete service for pharma track and trace compliance.
Patient safety is at the heart of what we do. We are committed to driving the industry towards a safer, better connected pharmaceutical supply chain, which is why we have been advocating serialization for over a decade.
In 2007, we took part in a European pharma track and trace project involving the use of data matrix codes and RFID tags on packaging throughout Europe. Then, in 2008, we became the first company to perform full serialization and aggregation from blister to pallet.
This experience means that we can integrate serialization into our service offering with minimum disruption. Our forward-thinking approach means that we’re constantly looking beyond the current regulations and preparing for future legislation changes.